{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T18:19:15Z","timestamp":1770574755635,"version":"3.49.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81673278"],"award-info":[{"award-number":["81673278"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.intimp.2023.109918","type":"journal-article","created":{"date-parts":[[2023,2,27]],"date-time":"2023-02-27T08:04:54Z","timestamp":1677485094000},"page":"109918","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Dihydroartemisinin-ursodeoxycholic acid conjugate is a potential treatment agent for inflammatory bowel disease"],"prefix":"10.1016","volume":"117","author":[{"given":"Jingfeng","family":"Yu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sihan","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaosu","family":"Zou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhengwu","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.intimp.2023.109918_b0005","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1038\/nm.2471","article-title":"The discovery of artemisinin (qinghaosu) and gifts from Chinese medicine","volume":"17","author":"Tu","year":"2011","journal-title":"Nat. Med"},{"key":"10.1016\/j.intimp.2023.109918_b0010","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.ejmech.2018.12.007","article-title":"Current scenario of artemisinin and its analogues for antimalarial activity","volume":"163","author":"Kumari","year":"2019","journal-title":"Eur. J. Med. Chem"},{"key":"10.1016\/j.intimp.2023.109918_b0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107658","article-title":"The birth of artemisinin","volume":"216","author":"Ma","year":"2020","journal-title":"Pharmacol. Ther"},{"issue":"9","key":"10.1016\/j.intimp.2023.109918_b0020","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.pt.2016.05.010","article-title":"Artemisinin Action and Resistance in Plasmodium falciparum","volume":"32","author":"Tilley","year":"2016","journal-title":"Trends. Parasitol"},{"key":"10.1016\/j.intimp.2023.109918_b0025","doi-asserted-by":"crossref","first-page":"10111","DOI":"10.1038\/ncomms10111","article-title":"Haem-activated promiscuous targeting of artemisinin in Plasmodium falciparum","volume":"6","author":"Wang","year":"2015","journal-title":"Nat. Commun"},{"issue":"6","key":"10.1016\/j.intimp.2023.109918_b0030","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1002\/ijc.25315","article-title":"First evidence that the antimalarial drug artesunate inhibits invasion and in vivo metastasis in lung cancer by targeting essential extracellular proteases","volume":"127","author":"Rasheed","year":"2010","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.intimp.2023.109918_b0035","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1146\/annurev-med-043015-123453","article-title":"Antimalarial Drugs as Immune Modulators: New Mechanisms for Old Drugs","volume":"68","author":"An","year":"2017","journal-title":"Annu. Rev. Med"},{"issue":"6","key":"10.1016\/j.intimp.2023.109918_b0040","doi-asserted-by":"crossref","first-page":"3023","DOI":"10.1002\/med.21842","article-title":"The immunosuppressive activity of artemisinin-type drugs towards inflammatory and autoimmune diseases","volume":"41","author":"Efferth","year":"2021","journal-title":"Med. Res. Rev"},{"key":"10.1016\/j.intimp.2023.109918_b0045","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.pharmthera.2016.07.002","article-title":"Immune suppressive properties of artemisinin family drugs","volume":"166","author":"Hou","year":"2016","journal-title":"Pharmacol. Ther"},{"issue":"23","key":"10.1016\/j.intimp.2023.109918_b0050","doi-asserted-by":"crossref","first-page":"10466","DOI":"10.7150\/thno.45211","article-title":"Dihydroartemisinin ameliorates psoriatic skin inflammation and its relapse by diminishing CD8(+) T-cell memory in wild-type and humanized mice","volume":"10","author":"Chen","year":"2020","journal-title":"Theranostics"},{"issue":"5","key":"10.1016\/j.intimp.2023.109918_b0055","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1038\/sj.bjp.0707137","article-title":"Investigation of the immunosuppressive activity of artemether on T-cell activation and proliferation","volume":"150","author":"Wang","year":"2007","journal-title":"Br. J. Pharmacol"},{"key":"10.1016\/j.intimp.2023.109918_b0060","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/435713","article-title":"Anti-inflammatory and immunoregulatory functions of artemisinin and its derivatives","volume":"2015","author":"Shi","year":"2015","journal-title":"Mediators. Inflamm"},{"issue":"16","key":"10.1016\/j.intimp.2023.109918_b0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2020.127338","article-title":"Studies on the stereoselective synthesis and immunosuppressive activity of dihydroartemisinin-O-glycoside derivatives","volume":"30","author":"Yu","year":"2020","journal-title":"Bioorg. Med. Chem. Lett"},{"issue":"8","key":"10.1016\/j.intimp.2023.109918_b0070","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1002\/art.30392","article-title":"Oral administration of artemisinin analog SM934 ameliorates lupus syndromes in MRL\/lpr mice by inhibiting Th1 and Th17 cell responses","volume":"63","author":"Hou","year":"2011","journal-title":"Arthritis. Rheum"},{"issue":"3","key":"10.1016\/j.intimp.2023.109918_b0075","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/cmi.2015.13","article-title":"Therapeutic effects of the artemisinin analog SM934 on lupus-prone MRL\/lpr mice via inhibition of TLR-triggered B-cell activation and plasma cell formation","volume":"13","author":"Wu","year":"2016","journal-title":"Cell. Mol. Immunol"},{"key":"10.1016\/j.intimp.2023.109918_b0080","doi-asserted-by":"crossref","DOI":"10.1038\/cmi.2017.87","article-title":"Water-soluble artemisinin derivatives as promising therapeutic immunosuppressants of autoimmune diseases","author":"Li","year":"2017","journal-title":"Cell. Mol. Immunol"},{"key":"10.1016\/j.intimp.2023.109918_b0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113754","article-title":"Study on the structure-activity relationship of dihydroartemisinin derivatives: Discovery, synthesis, and biological evaluation of dihydroartemisinin-bile acid conjugates as potential anticancer agents","volume":"225","author":"Zou","year":"2021","journal-title":"Eur. J. Med. Chem"},{"key":"10.1016\/j.intimp.2023.109918_b0090","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.intimp.2019.01.041","article-title":"Artemisinin enhances the anti-tumor immune response in 4T1 breast cancer cells in vitro and in vivo","volume":"70","author":"Cao","year":"2019","journal-title":"Int. Immunopharmacol"},{"issue":"1\u20132","key":"10.1016\/j.intimp.2023.109918_b0095","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ejphar.2011.06.044","article-title":"Artemisinins and immune system","volume":"668","author":"Shakir","year":"2011","journal-title":"Eur. J. Pharmacol"},{"issue":"1","key":"10.1016\/j.intimp.2023.109918_b0100","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1177\/2040622317738910","article-title":"Secukinumab: a review of the anti-IL-17A biologic for the treatment of psoriasis","volume":"9","author":"Frieder","year":"2018","journal-title":"Ther. Adv. Chronic. Dis"},{"issue":"1","key":"10.1016\/j.intimp.2023.109918_b0105","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1080\/14712598.2019.1555235","article-title":"Anti-IL17 therapies for psoriasis","volume":"19","author":"Silfvast-Kaiser","year":"2019","journal-title":"Expert. Opin. Biol. Ther"},{"issue":"13\u201314","key":"10.1016\/j.intimp.2023.109918_b0110","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1016\/j.intimp.2009.09.003","article-title":"SM934, a water-soluble derivative of arteminisin, exerts immunosuppressive functions in vitro and in vivo","volume":"9","author":"Hou","year":"2009","journal-title":"Int. Immunopharmacol"},{"issue":"4","key":"10.1016\/j.intimp.2023.109918_b0115","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/nri3405","article-title":"Molecular mechanisms of T cell co-stimulation and co-inhibition","volume":"13","author":"Chen","year":"2013","journal-title":"Nat. Rev. Immunol"},{"issue":"1","key":"10.1016\/j.intimp.2023.109918_b0120","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/nrm2083","article-title":"Integrating cell-signalling pathways with NF-kappaB and IKK function","volume":"8","author":"Perkins","year":"2007","journal-title":"Nat. Rev. Mol. Cell. Biol"},{"issue":"51","key":"10.1016\/j.intimp.2023.109918_b0125","doi-asserted-by":"crossref","first-page":"6680","DOI":"10.1038\/sj.onc.1209954","article-title":"Introduction to NF-kappaB: players, pathways, perspectives","volume":"25","author":"Gilmore","year":"2006","journal-title":"Oncogene"},{"issue":"12","key":"10.1016\/j.intimp.2023.109918_b0130","doi-asserted-by":"crossref","first-page":"11408","DOI":"10.1074\/jbc.M309063200","article-title":"Akt is a neutral amplifier for Th cell differentiation","volume":"279","author":"Arimura","year":"2004","journal-title":"J. Biol. Chem"},{"issue":"4","key":"10.1016\/j.intimp.2023.109918_b0135","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.celrep.2012.02.007","article-title":"PI3K-Akt-mTORC1-S6K1\/2 axis controls Th17 differentiation by regulating Gfi1 expression and nuclear translocation of RORgamma","volume":"1","author":"Kurebayashi","year":"2012","journal-title":"Cell. Rep"},{"issue":"1\u20132","key":"10.1016\/j.intimp.2023.109918_b0140","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.imlet.2011.06.011","article-title":"Antipsychotic drugs suppress the AKT\/NF-kappaB pathway and regulate the differentiation of T-cell subsets","volume":"140","author":"Chen","year":"2011","journal-title":"Immunol. Lett"},{"issue":"11","key":"10.1016\/j.intimp.2023.109918_b0145","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1084\/jem.20110462","article-title":"The Th17 immune response is controlled by the Rel-RORgamma-RORgamma T transcriptional axis","volume":"208","author":"Ruan","year":"2011","journal-title":"J. Exp. Med"},{"issue":"1","key":"10.1016\/j.intimp.2023.109918_b0150","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/ni.2785","article-title":"NF-kappaB control of T cell development","volume":"15","author":"Gerondakis","year":"2014","journal-title":"Nat. Immunol"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923002382?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923002382?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T18:00:35Z","timestamp":1761588035000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576923002382"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":30,"alternative-id":["S1567576923002382"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2023.109918","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dihydroartemisinin-ursodeoxycholic acid conjugate is a potential treatment agent for inflammatory bowel disease","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2023.109918","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109918"}}